LASEK results

Laser subepithelial keratomileusis (LASEK) has become a viable alternative to photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in selected patients. LASEK may decrease the complications associated with PRK, including postoperative pain and slow visual rehabilitation. In this article, the authors present the visual outcomes and complication rates of LASEK based on the retrospective case review of 101 consecutive patients (163 eyes) treated with LASEK surgery over the past 6 years. Seventy-eight percent of these eyes showed complete epithelial healing by day 3, and there were no incidents of recurrent erosions. As with LASIK, the achieved correction for LASEK was greater than the treatment dose (requiring undercorrection nomogram adjustments). Mean logMAR UCVA was 0.03 (20/20) at 1 year. LASEK seems to be a safe and effective option for patients who request refractive surgery.